Insurers face Medicare Advantage cost challenges due to unexpected healthcare utilization spikes. While some control costs effectively, others like Humana and CVS revise 2024 earnings forecasts downward. Factors include seniors seeking deferred care and shifts in enrollee health. Insurers plan benefit cuts or premium hikes to protect margins. Concerns linger about payment changes’ sufficiency and potential reductions in benefits for seniors.
Insurers are preparing for ongoing challenges with Medicare Advantage medical expenses, which dominated discussions in the fourth quarter between health insurers and investors. Increased healthcare utilization emerged unexpectedly in certain segments of each payer’s business, prompting varied outlooks for 2024.
While some insurers managed to control medical costs more effectively than anticipated, maintaining optimistic forecasts or even guiding for stronger performance in 2024, others like Humana and CVS revised their earnings outlooks downwards, citing persistently high medical costs.
Humana, in particular, presented a notably bleak outlook, with earnings expectations for 2024 falling far below analysts’ projections. Even insurers that weathered 2023 without financial setbacks are planning adjustments such as benefit cuts or premium increases to safeguard margins in Medicare Advantage, an area traditionally lucrative but now facing considerable challenges.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
The unexpected surge in medical costs is attributed to several factors, including seniors seeking deferred medical care during the COVID-19 pandemic and potential shifts in the health status of Medicare Advantage enrollees. Insurers may have overlooked early signs of increased acuity among members or underestimated demand due to factors like labor shortages or the health status of new enrollees.
The rise in medical costs is reflected in the medical loss ratio (MLR), a key metric indicating the proportion of healthcare premiums spent on clinical services. MLRs soared in the Medicare businesses of insurers during the fourth quarter, exacerbated by seasonal spending trends.
Insurers attributed the increase in medical costs to various factors, such as elevated outpatient care demand and higher expenses for seasonal diseases. Concerns were raised about rising inpatient costs, particularly impacting UnitedHealth and Humana, attributed to factors like expensive COVID admissions and changes in government regulations.
Looking ahead, insurers are bracing for continued challenges with utilization trends, compounded by weaker payment rates and regulatory changes. Adjustments such as benefit reductions, premium increases, or market exits are being considered to bolster profitability. Executives expressed skepticism about the adequacy of proposed payment changes for 2025 and warned of potential reductions in benefits for seniors if finalized rates do not adequately cover cost trends.